These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 36203528)
41. Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Liu C; Wu W; Xu M; Mi J; Xu L; Wang R Biomed Res Int; 2021; 2021():1028158. PubMed ID: 34423028 [TBL] [Abstract][Full Text] [Related]
42. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Li C; Wu ZH; Yuan K Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307 [TBL] [Abstract][Full Text] [Related]
43. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226 [TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma. Zhang S; Zhang W; Zhang J Oral Oncol; 2022 Mar; 126():105755. PubMed ID: 35144208 [TBL] [Abstract][Full Text] [Related]
45. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study. Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362 [TBL] [Abstract][Full Text] [Related]
46. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894857 [TBL] [Abstract][Full Text] [Related]
47. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
48. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis. Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474 [No Abstract] [Full Text] [Related]
49. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma. Yang C; Mei H; Peng L; Jiang F; Xie B; Li J Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497 [TBL] [Abstract][Full Text] [Related]
50. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Chen L; He X; Yi S; Liu G; Liu Y; Ling Y Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816 [TBL] [Abstract][Full Text] [Related]
51. Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood. Qian DC; Ulrich BC; Peng G; Zhao H; Conneely KN; Miller AH; Bruner DW; Eldridge RC; Wommack EC; Higgins KA; Shin DM; Saba NF; Smith AK; Burtness B; Park HS; Stokes WA; Beitler JJ; Xiao C Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1217-1228. PubMed ID: 36410685 [TBL] [Abstract][Full Text] [Related]
52. Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach. Deng L; Mi J; Ruan X; Zhang G; Pan Y; Wang R Mediators Inflamm; 2022; 2022():4007469. PubMed ID: 36299414 [TBL] [Abstract][Full Text] [Related]
53. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenografts. Linge A; Patil S; Grosser M; Lohaus F; Gurtner K; Kemper M; Gudziol V; Haim D; Nowak A; Tinhofer I; Zips D; Guberina M; Stuschke M; Balermpas P; Rödel C; Schäfer H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Boeke S; Gani C; Jöhrens K; Baretton GB; Löck S; Baumann M; Krause M; Radiother Oncol; 2024 Feb; 191():110055. PubMed ID: 38109944 [TBL] [Abstract][Full Text] [Related]
55. Identifying KRT20 as a Potential Key Gene in Lymphatic Metastasis of Head and Neck Squamous Cell Carcinoma. Zhang YF; Huang Q; Huang HY; Ren HL; Zhou L Technol Cancer Res Treat; 2022; 21():15330338221107710. PubMed ID: 35815926 [No Abstract] [Full Text] [Related]
57. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma. Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879 [TBL] [Abstract][Full Text] [Related]
58. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma. Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862 [TBL] [Abstract][Full Text] [Related]
59. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622 [TBL] [Abstract][Full Text] [Related]
60. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma. Zhao X; Cui L J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]